Contineum Therapeutics, Inc. (CTNM)
NASDAQ: CTNM · Real-Time Price · USD
10.64
-0.26 (-2.39%)
At close: Nov 14, 2025, 4:00 PM EST
10.66
+0.02 (0.19%)
After-hours: Nov 14, 2025, 4:10 PM EST
Contineum Therapeutics Market Cap
Contineum Therapeutics has a market cap or net worth of $311.09 million as of November 14, 2025. Its market cap has decreased by -29.36% in one year.
Market Cap
311.09M
Enterprise Value
134.17M
1-Year Change
-29.36%
Ranking
Category
Stock Price
$10.64
Market Cap Chart
Since the IPO on April 5, 2024, Contineum Therapeutics's market cap has decreased from $402.09M to $311.09M, a decrease of -22.63%. That is a compound annual growth rate of -14.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 14, 2025 | 311.09M | -17.62% |
| Dec 31, 2024 | 377.64M | -6.08% |
| Apr 5, 2024 | 402.09M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 918.02B |
| Johnson & Johnson | 472.05B |
| AbbVie | 410.67B |
| UnitedHealth Group | 291.55B |
| AstraZeneca | 276.16B |
| Novartis AG | 252.58B |
| Merck & Co. | 230.63B |
| Abbott Laboratories | 227.08B |